News
)
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
- Clinical
- Biopharma
- Virus
August 7 2025
)
Pioneering European collaboration to advance genetic diagnostics: introducing the European Long Read Innovation Network (ELRIN)
- Clinical
- Whole genome
- Oncology
- Multiomics
- Long-read
- Human genomics
February 28 2025
)
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
- Clinical
- Long-read
- Clinical research
- DNA
- Whole genome
August 9 2024
)
Oxford Nanopore releases new protocol for sequencing complete microbial isolate genomes ahead of ESCMID
- Clinical
- Protocols
- Infectious disease
April 25 2024
)
Oxford Nanopore, Yemaachi Biotech, and Global Partners Collaborate to Improve Childhood Leukemia Outcomes in Ghana
- Clinical
- Cancer research
- Human genomics
- High-throughput
- Population genomics
- Structural variation
September 9 2024
)
Nanopore sequencing demonstrates identification of antibiotic-resistant pathogens hidden to traditional methods in new study
- Clinical
- Infectious disease
- Real-time
July 15 2024
)
London Calling 2025 Technology Update: Oxford Nanopore unveils path to a true multiomics future
- Clinical
- London Calling
- Long-read
- Development
- Flow cell
- Workflow
May 21 2025
)
Cepheid and Oxford Nanopore Technologies partner to advance automated sequencing-based solutions
- Clinical
- Workflow
- Infectious disease
- Whole genome
- AMR
- Cancer research
April 9 2025
)
Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore simplex reads
- Clinical
- Assembly
- Long-read
- Research story
- Whole genome
- Workflow
April 18 2025
)
APAC Rare Disease Consortium launched to advance genomic innovation and rare disease diagnosis
- Clinical
- Population genomics
- Human genomics
- Long-read
- Structural variation
- DNA
February 27 2025
